by Collectif | 13 Jan, 2017 | Bioethics press synthesis | Embryo research and alternatives
The Bayer and Versant Ventures Companies have created a cell therapy firm called Therapeutics BlueRock in an attempt to develop iPS-based cell therapies [1] for cardiovascular diseases and neurodegenerative disorders. Based in New York and Boston, the Company will...
by Collectif | 13 Jan, 2017 | Bioethics press synthesis
A study published in the Nature journal has shed light on a new discovery by the research team led by Harvard School of Public Health T.H. Chan. Scientists have discovered a link between life expectancy and the splicing of RNA – an essential cell function which...
by Collectif | 13 Jan, 2017 | Bioethics press synthesis | MAP – Surrogacy
The British Company, Assured Fertility, specialising in IVF programs, offers commercial “satisfaction or money back” guarantees to infertile couples who want to have a child. The Company spent two and a half years studying Human Fertilisation and...
by Collectif | 13 Jan, 2017 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
Medical abortion is a “complex situation for parents and medical staff alike”. Drawing attention to this fact, obstetric personnel are calling for specific “support”. They describe the reality of a medical abortion: explanations...
by Collectif | 13 Jan, 2017 | Bioethics press synthesis | Genome
A team of American scientists led by Peter Glazer, Department of Genetics, Yale University (New Haven, United States), has developed “unparalleled” gene therapy to treat a blood disease in vivo. The Nature Communication journal published the results and...